| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1353-8020(13)70037-3 |
| P8608 | Fatcat ID | release_xagrpaxsxfftvjhdvigeeuqcte |
| P698 | PubMed publication ID | 24262170 |
| P2093 | author name string | Zhenyu Yue | |
| Ping-Yue Pan | |||
| P2860 | cites work | Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies | Q24307627 |
| Parkin is recruited selectively to impaired mitochondria and promotes their autophagy | Q24317471 | ||
| Interplay of LRRK2 with chaperone-mediated autophagy | Q24322747 | ||
| Hereditary early-onset Parkinson's disease caused by mutations in PINK1 | Q24337084 | ||
| Broad activation of the ubiquitin–proteasome system by Parkin is critical for mitophagy | Q24339224 | ||
| Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells | Q24651391 | ||
| LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model | Q24656256 | ||
| Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase | Q28116395 | ||
| Inhibition of LRRK2 kinase activity stimulates macroautophagy | Q28118311 | ||
| Identification of a candidate therapeutic autophagy-inducing peptide | Q28593490 | ||
| Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin | Q29547423 | ||
| Autophagy: from phenomenology to molecular understanding in less than a decade | Q29614174 | ||
| Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy | Q29614178 | ||
| Autophagy gone awry in neurodegenerative diseases | Q29614849 | ||
| Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases | Q33613123 | ||
| α-Synuclein impairs macroautophagy: implications for Parkinson's disease. | Q35005567 | ||
| α-Synuclein fate is determined by USP9X-regulated monoubiquitination | Q35558701 | ||
| Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway | Q35811884 | ||
| Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. | Q36066469 | ||
| Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain | Q36469322 | ||
| Distinct RolesIn Vivofor the Ubiquitin–Proteasome System and the Autophagy–Lysosomal Pathway in the Degradation of α-Synuclein | Q36653589 | ||
| TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity | Q36835587 | ||
| Lewy Body-like α-Synuclein Aggregates Resist Degradation and Impair Macroautophagy | Q36873680 | ||
| Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein | Q37278480 | ||
| The Role of Autophagy in Parkinson's Disease | Q37999796 | ||
| Lysosome-dependent pathways as a unifying theme in Parkinson's disease. | Q38038561 | ||
| Advances in the genetics of Parkinson disease | Q38121773 | ||
| LRRK2 as a modulator of lysosomal calcium homeostasis with downstream effects on autophagy | Q52735671 | ||
| Dangerous duet: LRRK2 and α-synuclein jam at CMA | Q54441670 | ||
| P921 | main subject | Parkinson's disease | Q11085 |
| autophagy | Q288322 | ||
| P304 | page(s) | S154-7 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Parkinsonism and Related Disorders | Q15762600 |
| P1476 | title | Genetic causes of Parkinson's disease and their links to autophagy regulation | |
| P478 | volume | 20 Suppl 1 |
| Q38212199 | Aberrant autophagy and parkinsonism: does correction rescue from disease progression? |
| Q47620111 | Age-Dependent Dopaminergic Neurodegeneration and Impairment of the Autophagy-Lysosomal Pathway in LRRK-Deficient Mice |
| Q28084605 | Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach |
| Q35865171 | Can the disease course in Parkinson's disease be slowed? |
| Q27016100 | Chaperone-mediated autophagy: roles in neurodegeneration |
| Q38605280 | Dissecting the role of Engrailed in adult dopaminergic neurons--Insights into Parkinson disease pathogenesis |
| Q52689754 | Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease |
| Q36284241 | Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis |
| Q34585744 | Eryptosis as a marker of Parkinson's disease |
| Q38237560 | Genetic convergence of Parkinson's disease and lysosomal storage disorders |
| Q90012246 | Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes |
| Q58693990 | Glucocerebrosidase deficiency promotes protein aggregation through dysregulation of extracellular vesicles |
| Q46264470 | High Performance Liquid Chromatography-Mass Spectrometry (LC-MS) Based Quantitative Lipidomics Study of Ganglioside-NANA-3 Plasma to Establish Its Association with Parkinson's Disease Patients. |
| Q39404657 | Necroptosis in neurodegenerative diseases: a potential therapeutic target |
| Q42610191 | Necrostatin-1 protection of dopaminergic neurons |
| Q26779424 | Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways |
| Q30369463 | Spermidine protects against α-synuclein neurotoxicity. |
| Q55399332 | TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons. |
| Q34513714 | The genetic background of Parkinson's disease: current progress and future prospects |
| Q91607344 | Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease |
| Q26739716 | Ubc13: the Lys63 ubiquitin chain building machine |
| Q38271411 | p600/UBR4 in the central nervous system |
Search more.